id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1991-P-0165-0002,FDA,FDA-1991-P-0165,"FDA/CDRH Hydergine Memo, dated 12/28/2011 to Division of Dockets Management",Other,Memo,2011-12-29T05:00:00Z,2011,12,2011-12-29T05:00:00Z,,2024-11-12T04:15:45Z,,1,0,0900006480f8ae25
FDA-1991-P-0165-0001,FDA,FDA-1991-P-0165,FDA/CDER  to Public Citizen Health Research Group- Letter,Other,Letter(s),2011-12-01T05:00:00Z,2011,12,2011-12-01T05:00:00Z,,2011-12-01T21:53:47Z,,0,0,0900006480f78e30